Cargando…
Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression
BACKGROUND: Lung adenocarcinoma (LUAD), which is the most common subtype of non-small cell lung cancer, is a leading course of cancer-related mortality worldwide. Recently, circular RNA (CircRNAs) has become a hot spot in cancer research because of its important role in tumorigenesis and development...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867743/ https://www.ncbi.nlm.nih.gov/pubmed/33569293 http://dx.doi.org/10.21037/tlcr-20-1062 |
_version_ | 1783648332133957632 |
---|---|
author | Wang, Yuanyong Wo, Yang Lu, Tong Sun, Xiao Liu, Ao Dong, Yanting Du, Wenxing Su, Wenhao Huang, Zhangfeng Jiao, Wenjie |
author_facet | Wang, Yuanyong Wo, Yang Lu, Tong Sun, Xiao Liu, Ao Dong, Yanting Du, Wenxing Su, Wenhao Huang, Zhangfeng Jiao, Wenjie |
author_sort | Wang, Yuanyong |
collection | PubMed |
description | BACKGROUND: Lung adenocarcinoma (LUAD), which is the most common subtype of non-small cell lung cancer, is a leading course of cancer-related mortality worldwide. Recently, circular RNA (CircRNAs) has become a hot spot in cancer research because of its important role in tumorigenesis and development and its superior stability. This study aims to clarify the role of circ-AASDH in LUAD and explore its competitive endogenous RNA mechanism. METHODS: The circ-AASDH, miR-140-3p and E2F transcription factor 7 (E2F7) mRNA expression levels were detected via qRT-PCR. CCK-8 and colony formation assay were used to evaluate the ability of cell proliferation. Transwell assay and wound healing assay were performed to measure the invasion and migration ability. Flow cytometry was used to detect the apoptosis of cells. Moreover, Sanger sequencing, RNaseR treatment and divergent primers were used to verify the circular structure. Luciferase reporter and RNA pull-down experiment were performed to characterize the ceRNA mechanism of circ-AASDH. The xenograft model of mice was established to investigate the tumorigenicity of circ-AASDH to LUAD in vivo. RESULTS: By screening for differentially expressed circRNAs, we found that circ-AASDH was highly expressed in LUAD tissues and cells and correlated with tumor size, clinical stage and poor prognosis. Transfection of si-circ-AASDH can inhibit the proliferation and migration of LUAD cells and promote apoptosis in vitro. In mechanism, circ-AASDH could be used as a sponge of miR-140-3p to weaken its inhibition on the expression of E2F7. Additionally, the overexpression of circ-AASDH could deduce the suppression of miR-140-3p on the malignant progression of LUAD cells. Besides, silencing of circ-AASDH inhibited cell proliferation and migration by regulating the expression of E2F7. Furthermore, overexpression of circ-AASDH can promote the growth of LUAD in vivo. CONCLUSIONS: Circ-AASDH/miR-140-3p/E2F7 regulating axis promoted the progression in LUAD. Our results provided ideas for understanding the biological mechanism of circ-AASDH and clarify potential therapeutic targets in LUAD. |
format | Online Article Text |
id | pubmed-7867743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-78677432021-02-09 Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression Wang, Yuanyong Wo, Yang Lu, Tong Sun, Xiao Liu, Ao Dong, Yanting Du, Wenxing Su, Wenhao Huang, Zhangfeng Jiao, Wenjie Transl Lung Cancer Res Original Article BACKGROUND: Lung adenocarcinoma (LUAD), which is the most common subtype of non-small cell lung cancer, is a leading course of cancer-related mortality worldwide. Recently, circular RNA (CircRNAs) has become a hot spot in cancer research because of its important role in tumorigenesis and development and its superior stability. This study aims to clarify the role of circ-AASDH in LUAD and explore its competitive endogenous RNA mechanism. METHODS: The circ-AASDH, miR-140-3p and E2F transcription factor 7 (E2F7) mRNA expression levels were detected via qRT-PCR. CCK-8 and colony formation assay were used to evaluate the ability of cell proliferation. Transwell assay and wound healing assay were performed to measure the invasion and migration ability. Flow cytometry was used to detect the apoptosis of cells. Moreover, Sanger sequencing, RNaseR treatment and divergent primers were used to verify the circular structure. Luciferase reporter and RNA pull-down experiment were performed to characterize the ceRNA mechanism of circ-AASDH. The xenograft model of mice was established to investigate the tumorigenicity of circ-AASDH to LUAD in vivo. RESULTS: By screening for differentially expressed circRNAs, we found that circ-AASDH was highly expressed in LUAD tissues and cells and correlated with tumor size, clinical stage and poor prognosis. Transfection of si-circ-AASDH can inhibit the proliferation and migration of LUAD cells and promote apoptosis in vitro. In mechanism, circ-AASDH could be used as a sponge of miR-140-3p to weaken its inhibition on the expression of E2F7. Additionally, the overexpression of circ-AASDH could deduce the suppression of miR-140-3p on the malignant progression of LUAD cells. Besides, silencing of circ-AASDH inhibited cell proliferation and migration by regulating the expression of E2F7. Furthermore, overexpression of circ-AASDH can promote the growth of LUAD in vivo. CONCLUSIONS: Circ-AASDH/miR-140-3p/E2F7 regulating axis promoted the progression in LUAD. Our results provided ideas for understanding the biological mechanism of circ-AASDH and clarify potential therapeutic targets in LUAD. AME Publishing Company 2021-01 /pmc/articles/PMC7867743/ /pubmed/33569293 http://dx.doi.org/10.21037/tlcr-20-1062 Text en 2021 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Wang, Yuanyong Wo, Yang Lu, Tong Sun, Xiao Liu, Ao Dong, Yanting Du, Wenxing Su, Wenhao Huang, Zhangfeng Jiao, Wenjie Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression |
title | Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression |
title_full | Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression |
title_fullStr | Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression |
title_full_unstemmed | Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression |
title_short | Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression |
title_sort | circ-aasdh functions as the progression of early stage lung adenocarcinoma by targeting mir-140-3p to activate e2f7 expression |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867743/ https://www.ncbi.nlm.nih.gov/pubmed/33569293 http://dx.doi.org/10.21037/tlcr-20-1062 |
work_keys_str_mv | AT wangyuanyong circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression AT woyang circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression AT lutong circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression AT sunxiao circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression AT liuao circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression AT dongyanting circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression AT duwenxing circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression AT suwenhao circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression AT huangzhangfeng circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression AT jiaowenjie circaasdhfunctionsastheprogressionofearlystagelungadenocarcinomabytargetingmir1403ptoactivatee2f7expression |